Therapeutic agent

Ketotifen

AnecdotalEvidence level
0Registered trials
1Conditions
0Study references

Evidence Summary

Evidence Level
Anecdotal
Mechanism
Not specified
Safety
Limited specific safety data in these populations. Review full prescribing information and consult specialist. Many agents used off-label or investigational.
Dosing
See linked studies/trials for reported doses and durations; typical protocols vary widely.
Dual H1 + mast cell stabilizer. Long track record; obs MCAS series. 1-2mg BID. 4-8wk to effect. When H1 alone insufficient.

Key Studies / References

  • See linked studies